Enterprise Mimetics

Enterprise Mimetics is building a new platform for universal vaccines against the world's most challenging pathogens: HIV, Influenza, HepC, Herpes, and more. Peptoid vaccines are pioneered and patented by the laboratory of Dr. Ellen Vitetta at The University of Southwestern Medical School. They enable the synthesis of vaccines against an entire class of a pathogen by mimicking a conserved structure across the entire class.

We’re Working with ATI to Find:


Advisors with experience in the biotechnology industry

Individuals interested in learning how scientists build a new universal vaccine against the world’s most challenging pathogens

Individuals with experience in commercializing academic scientific research

Think You Can Help? Drop Us a Line.

Join our Decision Day presentation Live:

The video below will begin live-streaming on September 10, 2014 at 6:30 PM CDT.

Enterprise Mimetics Logo